Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 6 hours agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Opinion: Wokeism is the world's newest religion
Idaho State Journal· 4 hours agoFauci uttered this pearl during a TV interview in which he criticized Republican lawmakers who were questioning him about his involvement in...
There’s A New COVID Variant, KP.3 – These Are The Symptoms
IFLScience· 7 days agoKP.3 is one of the FLiRT variants of SARS-CoV-2. The immune system can learn to recognize spike...
Hawaii-developed COVID home test kits being sold online
Honolulu Star-Advertiser· 4 days agoA locally developed COVID-19 test kit is now on the market as cases of the contagious disease are on...
Immune response study explains why some people don't get COVID-19
Medical Xpress· 3 days agoUsing single-cell sequencing, researchers from the Wellcome Sanger Institute, University College...
Covid-19 increases cardiovascular event risk in chronic respiratory patients
Clinical Trials Arena via Yahoo Finance· 4 days agoThe second significant finding was that the severity of Covid-19 infection modified the risk of...
Easy-to-Use CRISPR Tests Could Change How We Diagnose COVID and Other Illnesses
Scientific American· 2 days agoResearchers had already adapted the gene-editing technology CRISPR to identify genetic material from pathogens such as the COVID-causing SARS-CoV-
In Congress, Debate Rages About How To Prevent the Next Lab Leak
Reason.com via Yahoo News· 1 day agoThe Biden administration says its new guidance will make pandemic research safer. Critics say it...
COVID-19 origins fight heads to the Senate
The Hill· 3 days agoFauci wasn’t one of the witnesses on Tuesday, but his longtime Senate antagonist Rand Paul (R-Ky.) sharply questioned Robert F. Garry, professor at the...
Xencor (NASDAQ:XNCR) Price Target Cut to $40.00 by Analysts at Raymond James
ETF DAILY NEWS· 7 days agoXencor (NASDAQ:XNCR – Free Report) had its target price lowered by Raymond James from $58.00 to $40.00 in a research report report published on Friday, Benzinga reports. The firm currently has ...